[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356483-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356483-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multifocality-as-a-marker-of-aggressiveness-in-medullary-thyroid-carcinoma-a-retrospective-cohort-analysis-of-lymph-node-metastasis-and-recurrence","Multifocality as a marker of aggressiveness in medullary thyroid carcinoma - a retrospective cohort analysis of lymph node metastasis and recurrence","","The prognostic role of multifocality in medullary thyroid carcinoma (MTC) is controversial. This retrospective cohort analysis evaluated how multifocality relates to aggressiveness, lymph node metastasis (LNM), and survival. A total of 186 MTC cases were followed for a median 59 months, and logistic/Cox regression with subgroup and ROC analyses assessed tumor-foci number and size parameters, using Kaplan–Meier methods for survival end points.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multifocality-as-a-marker-of-aggressiveness-in-medullary-thyroid-carcinoma-a-retrospective-cohort-analysis-of-lymph-node-metastasis-and-recurrence/356483/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multifocality-as-a-marker-of-aggressiveness-in-medullary-thyroid-carcinoma-a-retrospective-cohort-analysis-of-lymph-node-metastasis-and-recurrence/356483.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about multifocality in medullary thyroid carcinoma?","Question",{"text":63,"@type":64},"It evaluates whether multifocality is associated with tumor aggressiveness, lymph node metastasis, and survival outcomes in MTC, including effects of multifocality-related parameters such as tumor-foci number and tumor diameter.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the relationship between multifocality and lymph node metastasis assessed?",{"text":68,"@type":64},"The study retrospectively analyzed 186 MTC cases and used multivariate logistic analysis to test multifocality’s independent prediction of LNM, along with ROC analysis to identify tumor-size cut-offs for LNM risk.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about recurrence and survival in multifocal cases?",{"text":72,"@type":64},"Multifocality independently predicted recurrence and showed significantly worse progression-free survival, with evidence of a dose–response relationship with lesion number. Overall survival differences were not statistically significant.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356483,1790188656,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Multifocality as a marker of aggressiveness in medullary thyroid carcinoma: a retrospective cohort analysis of lymph node metastasis and recurrence  \nYidan Lu1,‡, Ziyi Chen2,‡, Jing Yang1, , Tian Jiang1, Na Feng1, Jincao Yao1,3,4,5, Di Ou1,2,3,4, Zhiyan Jin1, Liyu Chen1,5, Chen Yang1,5, Dong Xu1,3,4,5,*, , Lingyan Zhou1,*,   \n1 Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China  \n2 Department of Ultrasound, Taizhou Cancer Hospital, Taizhou, Zhejiang 317502, China  \n3 Interventional Medicine and Engineering Research Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China  \n4Wenling Medical Big Data and Artificial Intelligence Research Institute, Taizhou, Zhejiang 317502, China  \n5Zhejiang Provincial Research Center for Innovative Technology and Equipment in Interventional Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China  \n*Corresponding authors. Dong Xu, Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, No. 1 Banshan East Road, Gongshu District, Hangzhou 310022, Zhejiang Province, China. E-mail: [xudong@zjcc.org.cn](xudong@zjcc.org.cn); Lingyan Zhou, Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, No. 1 Banshan East Road, Gongshu District, Hangzhou 310022, Zhejiang Province, China.  \nE-mail: [zhouly@zjcc.org.cn](zhouly@zjcc.org.cn).  \n‡These authors contributed equally to this work.  \nAbstract  \nBackground: The prognostic role of multifocality in medullary thyroid carcinoma (MTC) is controversial. This study evaluated multifocality’s association with aggressiveness, lymph node metastasis (LNM), and survival, focusing on multifocality-related parameters (such as number of tumor foci, tumor diameter).  \nMethods: We retrospectively analyzed 186 MTC cases (136 unifocal, 50 multifocal) with a median 59-month follow-up (95% CI: 52-66). Multivariate logistic analysis and Cox regression models assessed multifocality’s impact on LNM and recurrence, with detailed subgroup analyses. Diagnostic performance of tumor size parameters was evaluated using receiver operating characteristic (ROC) analysis, while survival outcomes were assessed via Kaplan–Meier method.  \nResults: Multifocal tumors exhibited significantly more aggressive features, including: (1) higher preoperative calcitonin (1226.7 ± 751.9 vs 706.6 ± 704.2 ng/L, P \u003C .001); (2) increased capsular invasion (68% vs 32%, odds ratio [OR] = 5.8, 95% CI: 2.32-14.53); and (3) more frequent intraglandular spread (54% vs 18%, OR = 6.05, 95% CI: 1.47-24.92). Multifocality independently predicted both LNM (OR = 3.35, 95% CI: 1.22-9.25, P = .019) and recurrence (hazard ratio [HR] = 6.59, 95% CI: 2.48-17.53, P \u003C .001). ROC analysis identified optimal LNM cut-offs at 13.5 mm (largest focus) and 16.5 mm (total tumor diameter). Subgroup analyses revealed: (1) bifocal conferred highest LNM risk (OR = 8.51 vs unifocal, 95% CI: 1.74-41.69, P = .008); (2) recurrence risk showed dose–response relationship with lesion number (bifocal: HR = 4.89, 95% CI: 1.88- 12.70, P = .001; ≥3 foci: HR = 5.86, 95% CI: 1.54-22.33, P = .01). Survival analysis demonstrated significantly worse progression-free survival in multifocal cases (P \u003C .001), persisting beyond 2 years (P = .001), though overall survival difference was nonsignificant (P = .168).  \nReceived: July 30, 2025. Accepted: February 19, 2026 © The Author(s) 2026. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestri","cbCaimCj1mn75clm","https://ap.wps.com/l/cbCaimCj1mn75clm","pdf",1881773,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Implications for Practice\n# Introduction","[{\"question\":\"What question does the study address about multifocality in medullary thyroid carcinoma?\",\"answer\":\"It evaluates whether multifocality is associated with tumor aggressiveness, lymph node metastasis, and survival outcomes in MTC, including effects of multifocality-related parameters such as tumor-foci number and tumor diameter.\"},{\"question\":\"How was the relationship between multifocality and lymph node metastasis assessed?\",\"answer\":\"The study retrospectively analyzed 186 MTC cases and used multivariate logistic analysis to test multifocality’s independent prediction of LNM, along with ROC analysis to identify tumor-size cut-offs for LNM risk.\"},{\"question\":\"What did the results show about recurrence and survival in multifocal cases?\",\"answer\":\"Multifocality independently predicted recurrence and showed significantly worse progression-free survival, with evidence of a dose–response relationship with lesion number. Overall survival differences were not statistically significant.\"}]","Multifocality as a marker of aggressiveness in medullary thyroid carcinoma - a retrospective cohort analysis of lymph node metastasis and recurrence | PDF",1790125521,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f7c3624f037966194832e27c367cd45.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03626d8783925943b7ff5cc5fd5a999a.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02ccb06eeb60e672c5f294c005fa644a.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3203b53b633c3efdeb56e74b7d784c35.webp",980,1287]